Key facts
- It has raised $18.4M across 1 recorded rounds; the latest was Early Stage VC ($11.0M) in Nov 2024.
- Notable investors include Joyance Partners, Founderful, Swisscom Ventures, Amplo, GreyMatter (US) — 7 tracked in total.
- Kyan Health has filed 1 Form D with the SEC, most recently Nov 2024 ($11.0M sold to 22 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Kyan Health
Funding rounds
1 roundsAbout Kyan Health
Developer of a mental healthcare platform designed to improve how people feel and perform at work. The company's tools and resources provide fully personalized, evidence-based mental health and well-being support, counseling services, multilingual counseling, leadership training, and predictive analytics to proactively address mental well-being, reduce turnover, and improve productivity, enabling leading companies and their employees to experience psychological safety.
- Sector
- Healthcare
- HQ
- Zollikon, Switzerland
- Founded
- 2021
- Employees
- 97
- Website
- kyanhealth.com/
- Ownership
- Privately Held (backing)
Kyan Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kyan Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kyan Health in its N-PORT filings yet. We sweep new filings monthly.